[HTML][HTML] Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization

B Sigvant, B Kragsterman, M Falkenberg… - Journal of vascular …, 2016 - Elsevier
Objective Peripheral artery disease (PAD) is common worldwide, and PAD patients are
increasingly offered lower limb revascularization procedures. The aim of this population …

[HTML][HTML] The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral …

B Sigvant, F Lundin, E Wahlberg - European Journal of Vascular and …, 2016 - Elsevier
Objective Peripheral arterial disease (PAD) afflicts up to 20% of older people and is
associated with a high risk of cardiovascular (CV) morbidity, but a rather low risk of …

[HTML][HTML] Characteristics and outcome of patients hospitalised for lower extremity peripheral artery disease in France: the COPART Registry

JP Cambou, V Aboyans, J Constans, P Lacroix… - European Journal of …, 2010 - Elsevier
OBJECTIVES: To assess the current 'real-world'management of hospitalised patients with
lower-extremity peripheral artery disease (LE-PAD) and to assess the 1-year outcome …

[HTML][HTML] Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: results from a …

B Sigvant, P Hasvold, B Kragsterman… - Journal of vascular …, 2017 - Elsevier
Objective Long-term progression of peripheral arterial disease (PAD) as initial manifestation
of atherosclerotic arterial disease is not well described. Cardiovascular (CV) risk was …

Medication underuse during long-term follow-up in patients with peripheral arterial disease

SE Hoeks, WJM Scholte op Reimer… - … Quality and Outcomes, 2009 - Am Heart Assoc
Background—Patients with peripheral arterial disease constitute a high-risk population.
Guideline-recommended medical therapy use is therefore of utmost importance. The aims of …

Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation

C Bianchi, V Montalvo, HW Ou, V Bishop… - Annals of vascular …, 2007 - Elsevier
The pharmacologic treatment of the cardiovascular comorbidities in patients with peripheral
arterial disease (PAD) can have a profound effect on the outcomes of these patients …

Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease: a propensity score-matched analysis

SL Parvar, L Ngo, J Dawson, SJ Nicholls… - European heart …, 2022 - academic.oup.com
Aims Peripheral artery disease (PAD) revascularization can be performed by either
endovascular or open surgical approach. Despite increasing use of endovascular …

Profile of cardiovascular risk factors and mortality in patients with symptomatic peripheral arterial disease

SG Zanati, GG Mouraria, LS Matsubara, M Giannini… - Clinics, 2009 - SciELO Brasil
INTRODUCTION: The present study examines cardiovascular risk factor profiles and 24-
month mortality in patients with symptomatic peripheral arterial disease. DESIGN STUDY …

Observational study of the medical management of patients with peripheral artery disease

A Saratzis, NEM Jaspers, B Gwilym… - Journal of British …, 2019 - academic.oup.com
Background Previous research has suggested that patients with peripheral artery disease
(PAD) are not offered adequate risk factor modification, despite their high cardiovascular …

Cardiovascular long-term outcome and prophylactic treatment patterns in peripheral arterial disease in a population-based cohort

F Sartipy, F Lundin, E Wahlberg… - European Heart Journal …, 2019 - academic.oup.com
Aims This study evaluates 10-year follow-up data on associated comorbidity, mortality, and
pharmacological treatment patterns for men and women with different stages of peripheral …